| Product Information |
|
| Registration Number |
DRP-5945-01
|
| Generic Name |
Sitagliptin
|
| Brand Name |
Xelevia
|
| Dosage Strength |
50 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription Drug (Rx)
|
| Packaging |
In a box of 4 PVDC/PE/PVC White Opaque Blister x 7's; In a box of 1 PVDC/PE/PVC White Opaque Blister x 7's (as physician's sample)
|
| Pharmacologic Category |
Dipeptidyl Peptidase-4 Inhibitor
|
| Manufacturer |
Merck Sharp & Dohme Ltd.
|
| Country of Origin |
United Kingdom
|
| Trader |
|
| Importer |
Merck Sharp & Dohme (I.A.) LLC
|
| Distributor |
Essex Pharmaceuticals, Inc.
|
| Application Type |
Renewal
|
| Issuance Date |
19 November 2024
|
| Expiry Date |
28 January 2030
|